Eloxx Pharmaceuticals' Reverse Merger Round

Eloxx Pharmaceuticals raised a round of funding on December 22, 2017. Investors include Sevion Therapeutics.

Eloxx Pharmaceuticals (NASDAQ:ELOX) is a clinical stage company developing therapeutics for genetic diseases caused by non-sense mutations.…

Articles about Eloxx Pharmaceuticals' Reverse Merger Round: